• 1
    Tato, C. M. and Cua, D. J., Reconciling id, ego, and superego within interleukin-23. Immunol. Rev. 2008. 226: 103111.
  • 2
    Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F. et al., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000. 13: 715725.
  • 3
    Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L., Interleukin-23 promotes a distinct CD4T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003. 278: 19101914.
  • 4
    Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J. and Ouyang, W., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007. 445: 648651.
  • 5
    Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179189.
  • 6
    Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 cells. Annu. Rev. Immunol. 2009. 27: 485517.
  • 7
    Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744748.
  • 8
    Kreymborg, K., Etzensperger, R., Dumoutier, L., Haak, S., Rebollo, A., Buch, T., Heppner, F. L. et al., IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 2007. 179: 80988104.
  • 9
    Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. and Iwakura, Y., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566573.
  • 10
    Schulz, S. M., Kohler, G., Schutze, N., Knauer, J., Straubinger, R. K., Chackerian, A. A., Witte, E. et al., Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J. Immunol. 2008. 181: 78917901.
  • 11
    Munoz, M., Heimesaat, M. M., Danker, K., Struck, D., Lohmann, U., Plickert, R., Bereswill, S. et al., Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 2009. 206: 30473059.
  • 12
    Wolk, K., Witte, E., Witte, K., Warszawska, K. and Sabat, R., Biology of interleukin-22. Semin. Immunopathol. 2010. 32: 1731.
  • 13
    Zenewicz, L. A. and Flavell, R. A., IL-22 and inflammation: leukin' through a glass onion. Eur. J. Immunol. 2008. 38: 32653268.
  • 14
    Ouyang, W. and Valdez, P., IL-22 in mucosal immunity. Mucosal Immunol. 2008. 1: 335338.
  • 15
    Colonna, M., Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009. 31: 1523.
  • 16
    Liang, S. C., Tan, X. Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M. and Fouser, L. A., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006. 203: 22712279.
  • 17
    Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J. K., Doherty, J. M. et al., A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009. 457: 722725.
  • 18
    Takatori, H., Kanno, Y., Watford, W. T., Tato, C. M., Weiss, G., Ivanov, I. I., Littman, D. R. and O'Shea, J. J., Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009. 206: 3541.
  • 19
    Goto, M., Murakawa, M., Kadoshima-Yamaoka, K., Tanaka, Y., Nagahira, K., Fukuda, Y. and Nishimura, T., Murine NKT cells produce Th17 cytokine interleukin-22. Cell Immunol. 2009. 254: 8184.
  • 20
    Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J. C. and Stockinger, B., The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008. 453: 106109.
  • 21
    O'Connor, W., Jr., Zenewicz, L. A. and Flavell, R. A., The dual nature of T(H)17 cells: shifting the focus to function. Nat. Immunol. 2010. 11: 471476.
  • 22
    Geboes, L., Dumoutier, L., Kelchtermans, H., Schurgers, E., Mitera, T., Renauld, J. C. and Matthys, P., Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 2009. 60: 390395.
  • 23
    Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Stevens, S. and Flavell, R. A., Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008. 29: 947957.
  • 24
    Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M. and Flavell, R. A., Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007. 27: 647659.
  • 25
    Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A. et al., IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008. 14: 275281.
  • 26
    Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R. et al., Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008. 14: 282289.
  • 27
    Radtke, F. and Raj, K., The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat. Rev. Cancer 2003. 3: 756767.
  • 28
    Osborne, B. A. and Minter, L. M., Notch signalling during peripheral T-cell activation and differentiation. Nat. Rev. Immunol. 2007. 7: 6475.
  • 29
    Alam, M. S., Maekawa, Y., Kitamura, A., Tanigaki, K., Yoshimoto, T., Kishihara, K. and Yasutomo, K., Notch signaling drives IL-22 secretion in CD4+T cells by stimulating the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 2010. 107: 59435948.
  • 30
    Tagawa, Y., Matthys, P., Heremans, H., Dillen, C., Zaman, Z., Iwakura, Y. and Billiau, A., Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice. J. Leukoc. Biol. 2000. 67: 9096.
  • 31
    Nagata, T., McKinley, L., Peschon, J. J., Alcorn, J. F., Aujla, S. J. and Kolls, J. K., Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J. Immunol. 2008. 181: 74737479.
  • 32
    Wahl, C., Wegenka, U. M., Leithauser, F., Schirmbeck, R. and Reimann, J., IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency. J. Immunol. 2009. 182: 45214528.
  • 33
    Ghilardi, N., Kljavin, N., Chen, Q., Lucas, S., Gurney, A. L. and De Sauvage, F. J., Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 2004. 172: 28272833.
  • 34
    Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J. and Littman, D. R., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006. 126: 11211133.
  • 35
    Mukherjee, S., Schaller, M. A., Neupane, R., Kunkel, S. L. and Lukacs, N. W., Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J. Immunol. 2009. 182: 73817388.
  • 36
    Tagawa, Y., Sekikawa, K. and Iwakura, Y., Suppression of concanavalin A-induced hepatitis in IFN-gamma(–/–) mice, but not in TNF-alpha(–/–) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J. Immunol. 1997. 159: 14181428.
  • 37
    Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., III, Tannahill, C. L., Solorzano, C. C., Norman, J. et al., Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J. Immunol. 1998. 160: 40824089.
  • 38
    Yang, X. O., Panopoulos, A. D., Nurieva, R., Chang, S. H., Wang, D., Watowich, S. S. and Dong, C., STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007. 282: 93589363.
  • 39
    Mathur, A. N., Chang, H. C., Zisoulis, D. G., Stritesky, G. L., Yu, Q., O'Malley J, T., Kapur, R. et al., Stat3 and Stat4 direct development of IL-17-secreting Th cells. J. Immunol. 2007. 178: 49014907.
  • 40
    Morishima, N., Mizoguchi, I., Takeda, K., Mizuguchi, J. and Yoshimoto, T., TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23. Biochem. Biophys. Res. Commun. 2009. 386: 105110.
  • 41
    Kim, S. H., Henry, E. C., Kim, D. K., Kim, Y. H., Shin, K. J., Han, M. S., Lee, T. G. et al., Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol. 2006. 69: 18711878.
  • 42
    Lafdil, F., Wang, H., Park, O., Zhang, W., Moritoki, Y., Yin, S., Fu, X. Y. et al., Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology 2009. 137: 21252135, e2121–e2122.
  • 43
    Kobayashi, E., Kobayashi, M., Tsuneyama, K., Fukami, T., Nakajima, M. and Yokoi, T., Halothane-induced liver injury is mediated by interleukin-17 in mice. Toxicol. Sci. 2009. 111: 302310.
  • 44
    Sonnenberg, G. F., Nair, M. G., Kirn, T. J., Zaph, C., Fouser, L. A. and Artis, D., Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J. Exp. Med. 2010. 207: 12931305.
  • 45
    Satoh-Takayama, N., Vosshenrich, C. A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J. J. et al., Microbial flora drives interleukin 22 production in intestinal NKp46+cells that provide innate mucosal immune defense. Immunity 2008. 29: 958970.
  • 46
    Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. and Sallusto, F., Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009. 10: 857863.
  • 47
    Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. and Spits, H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009. 10: 864871.
  • 48
    Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K. et al., Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002. 17: 375387.
  • 49
    Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T. and Akira, S., Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 1998. 161: 46524660.
  • 50
    Kaplan, M. H., Sun, Y. L., Hoey, T. and Grusby, M. J., Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996. 382: 174177.
  • 51
    Yoshimoto, T., Takahama, Y., Wang, C. R., Yoneto, T., Waki, S. and Nariuchi, H., A pathogenic role of IL-12 in blood-stage murine malaria lethal strain Plasmodium berghei NK65 infection. J. Immunol. 1998. 160: 55005505.
  • 52
    Owaki, T., Asakawa, M., Kamiya, S., Takeda, K., Fukai, F., Mizuguchi, J. and Yoshimoto, T., IL-27 suppresses CD28-medicated IL-2 production through suppressor of cytokine signaling 3. J. Immunol. 2006. 176: 27732780.